In this year’s forward view, we consider issues ranging from fixed recoverable costs in clinical negligence claims, claims resulting from COVID-19 treatment, major inquiries, clinical trials and healthcare technology.

This year is likely to see a resurgence of non-Covid trials which have been postponed or paused in the last two years, and new trials for Covid treatments and vaccines (e.g. those based on conventional vaccine technology).

The Court of Appeal held that the Chief Constable was liable for any disability discrimination by the statutory police misconduct panel that had determined disciplinary allegations against the claimant police officer.

The pandemic has seen an acceleration in the use of technology: remote GP consultations, the use of apps for ‘track and trace’ and AI as a diagnostic reporting tool (e.g. in radiology), with legal issues likely to centre on information governance.

Safety of two medicines (Primodos and Sodium Valproate) and one device (pelvic mesh) was at the heart of the report of the Independent Medicines and Medical Devices Safety Review. Read the latest update on this topic.

This is a useful judgment for insurers when considering multiple claims which follow the actions of a single individual. Read on for a summary of the case and what it means for insurers.

We summarise NHSE&I's operational guidance to assist you with preparing and implementing the new regulations requiring healthcare providers to ensure that certain workers have received two doses of an approved COVID-19 vaccine.

The RSH launched the proposed tenant satisfaction measures last month. This insight sets out the proposals for neighbourhood management and anti-social behaviour (ASB), an issue affecting many landlords.

The Department of Health and Social Care is consulting on proposed changes to employee contribution rates to the NHS Pension Scheme. We summarise the key proposals you need to know about.

As 2021 draws to a close, we review some of the key decisions over the last eleven months which impact healthcare and those who provide indemnity to this sector.

The COVID-19 pandemic continues to pose significant workforce issues for healthcare organisations regarding the services they provide and the risks to staff. Here we share our FAQs in relation to these policies and communications with staff generally.

The Government published its response to its consultation on the Green Paper on Transforming Public Procurement, summarising its position on issues and how it intends to deal with them. Read on for a summary of the most notable changes that we can expect.